NuvaRing Settlement to Move Forward for 3,800 Plaintiffs

Merck confirmed last week that it will not opt-out of a recent agreement to settle NuvaRing lawsuits, which will allow the $100 million deal reached to resolve approximately 3,800 cases to move forward as planned.

In a statement issued on June 5, Merck indicated that it stands behind the safety of NuvaRing and provided an update on the settlement reached earlier this year to resolve litigation the drug maker has been facing for years.

The NuvaRing settlement was first announced on February 7, resolving the entire litigation for a total payment by Merck of $100 million. Merck had an option to cancel the agreement if at least 95% of all eligible plaintiffs failed to participate, with additional thresholds for cases raising specific types of injuries.

Learn More About

NuvaRing Lawsuits

Side effects of NuvaRing may increase risk of blood clots, pumonary embolism, DVT, death. Lawsuits pending.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Merck indicated last week that only an “immaterial number of cases have opted out of the settlement,” and the drug maker confirmed that the agreement will move forward to resolve claims filed in federal and state courts, as well as unfiled claims. The company indicates that insurance coverage will be used to fund the settlement.

NuvaRing Safety Concerns

NuvaRing is a vaginal contraceptive ring, which delivers a combination of ethinyl estradiol and etonogestrel to prevent pregnancy. It is inserted into the vagina once-a-month, and has been promoted as a “hassle free” form of birth control.

Although Merck continues to maintain that there is “substantial evidence to support the safety profile and efficacy of NuvaRing,” lawsuits alleged that the drug maker failed to adequately warn women and the medical community about an increased risk of blood clots experienced among users of the birth control ring,

In May 2012, a study in the British Medical Journal found that the side effects of NuvaRing doubled the risk of blood clots for women compared to those taking birth control pills containing levonorgestrel. Compared to women not taking any form of birth control, researchers found that women using the NuvaRing were more than 6.5 times likely to suffer blood clots. Those blood clots can lead to severe complications, including deep vein thrombosis and pulmonary embolism.

The company says that both its own studies and a study by the FDA show no significantly increased risk when comparing NuvaRing to most birth control pills

“We stand behind the research that supported the approval of NuvaRing, and our continued work to monitor the safety of the medicine,” wrote Merck in the statement issued last week. “Merck is pleased to be able to offer an alternative to the pill for women seeking to avoid unintended pregnancy and for whom a [combined hormonal contraceptive] is deemed medically appropriate by their healthcare provider.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge
Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge (Posted today)

The judge overseeing Ozempic lawsuits consolidated in federal court has died, requiring a new judge to be assigned to oversee coordinated pretrial proceedings over claims the diabetes drug and similar medications caused stomach paralysis and other intestinal complications.

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted 2 days ago)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.